4D Molecular: Reiterate 'Buy' With Wet AMD 4D-150 Program On Track And Phase 3 DME Trial Underway
AI Summary
The headline reiterates a Buy view on 4D Molecular, saying its 4D-150 program for wet age-related macular degeneration is on track and a Phase 3 trial for diabetic macular edema is underway. The report concerns the company’s clinical development programs.